DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Tyramine is an investigational drug.
There have been 16 clinical trials for Tyramine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2016.
The most common disease conditions in clinical trials are Hypercholesterolemia, Hyperlipoproteinemia Type II, and Depressive Disorder. The leading clinical trial sponsors are Sanofi, Regeneron Pharmaceuticals, and New York State Psychiatric Institute.
There are two US patents protecting this investigational drug and twenty-one international patents.
Recent Clinical Trials for Tyramine
|A Study of the Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome||Pharmascience Inc.||Phase 2|
|A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood Pressure||Boehringer Ingelheim||Phase 1|
|Coenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy||Zagazig University||N/A|
Top disease conditions for Tyramine
Top clinical trial sponsors for Tyramine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Tyramine||Start Trial||Phosphonate compounds for treatment of medical disorders||Achillion Pharmaceuticals, Inc. (New Haven, CT)||Start Trial|
|Tyramine||Start Trial||Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity||Chiesi Farmaceutici S.p.A. (Parma, IT)||Start Trial|
|Tyramine||Start Trial||Use of inhibitors of Bruton'S tyrosine kinase (Btk)||Pharmacyclics LLC (Sunnyvale, CA)||Start Trial|
|Tyramine||Start Trial||Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity||The University of North Carolina at Chapel Hill (Chapel Hill, NC)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Tyramine||World Intellectual Property Organization (WIPO)||2017035357||2035-08-26||Start Trial|
|Tyramine||World Intellectual Property Organization (WIPO)||2016033337||2034-08-27||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|